Sichuan Kelun Pharmaceutical Co Ltd (002422) — Free Cash Flow Generation Index
Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Free Cash Flow Generation Index of 0.27x as of September 2025. Free cash flow of CN¥143.72 Million represents 0% of operating cash flow (CN¥537.31 Million). Explore 002422 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sichuan Kelun Pharmaceutical Co Ltd Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Sichuan Kelun Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Sichuan Kelun Pharmaceutical Co Ltd.
Annual Free Cash Flow Generation for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Year-by-year Free Cash Flow Generation Index for Sichuan Kelun Pharmaceutical Co Ltd. Check Sichuan Kelun Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥1.02 Billion | CN¥2.64 Billion | CN¥1.62 Billion | ▼ -38.4% |
| 2024 | 0.63x | CN¥2.81 Billion | CN¥4.49 Billion | CN¥1.68 Billion | ▼ -6.3% |
| 2023 | 0.67x | CN¥3.57 Billion | CN¥5.34 Billion | CN¥1.77 Billion | ▼ -6.3% |
| 2022 | 0.71x | CN¥2.23 Billion | CN¥3.13 Billion | CN¥896.02 Million | ▲ +9.4% |
| 2021 | 0.65x | CN¥1.86 Billion | CN¥2.85 Billion | CN¥990.56 Million | ▲ +46.4% |
| 2020 | 0.45x | CN¥988.50 Million | CN¥2.22 Billion | CN¥1.23 Billion | ▲ +11.5% |
| 2019 | 0.40x | CN¥885.70 Million | CN¥2.22 Billion | CN¥1.33 Billion | ▼ -27.3% |
| 2018 | 0.55x | CN¥1.62 Billion | CN¥2.95 Billion | CN¥1.33 Billion | ▲ +276.6% |
| 2017 | -0.31x | CN¥-374.65 Million | CN¥1.20 Billion | CN¥1.48 Billion | ▼ -250.9% |
| 2016 | 0.21x | CN¥355.95 Million | CN¥1.73 Billion | CN¥1.37 Billion | ▲ +142.6% |
| 2015 | -0.48x | CN¥-600.65 Million | CN¥1.24 Billion | CN¥1.84 Billion | ▲ +61.6% |
| 2014 | -1.26x | CN¥-1.54 Billion | CN¥1.22 Billion | CN¥2.76 Billion | ▼ -9.8% |
| 2013 | -1.15x | CN¥-1.21 Billion | CN¥1.05 Billion | CN¥2.26 Billion | ▲ +80.5% |
| 2012 | -5.89x | CN¥-2.37 Billion | CN¥402.77 Million | CN¥2.77 Billion | ▼ -21.5% |
| 2011 | -4.85x | CN¥-1.66 Billion | CN¥342.93 Million | CN¥2.00 Billion | ▼ -45.3% |
| 2010 | -3.34x | CN¥-497.93 Million | CN¥149.29 Million | CN¥647.22 Million | ▼ -3299.0% |
| 2009 | -0.10x | CN¥-24.60 Million | CN¥250.69 Million | CN¥275.29 Million | ▼ -294.1% |
| 2008 | -0.02x | CN¥-5.50 Million | CN¥221.08 Million | CN¥226.58 Million | ▲ +36.7% |
| 2007 | -0.04x | CN¥-6.63 Million | CN¥168.42 Million | CN¥175.05 Million | — |